Jan-Michael Werner

University of Cologne

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (25)

Collaborators (9)

Norbert Galldiks

Jurij Rosen

University Hospital

Matthias Preusser

Medical University

Felix M. Mottaghy

RWTH Aachen University

Manuel Montesinos-Rongen

University Hospital Bonn

Christoph Lerche

Head of PET Group

Forschungszentrum Jülich

Michael Platten

Heidelberg University

Veronika Dunkl

University Hospital Bonn

Florien Boele

UNITED KINGDOM

Jan-Michael Werner

Research Interests

Explore related searches

Contact this professor

Articles (25)

Diagnosis of treatment-related changes in children and adolescents with brain and spinal tumors: a cost-effectiveness analysis using MRI and [18 F]FET PET.

Borderline Findings in O-(2-[(18)F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice

Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas

Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: an international cross-sectional investigation.

Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by O-(2-[18F]fluoroethyl)-l-tyrosine PET

The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse.

The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse

Chairing scientific sessions at international Neuro-Oncology meetings: An EANO guide for early-career professionals

Chairing scientific sessions at international Neuro-Oncology meetings: An EANO guide for early-career professionals

Monitoring Patients with Glioblastoma by Using a Large Language Model: Accurate Summarization of Radiology Reports with GPT-4

Example of Artificial Intelligence-Based Decision Support for Amino Acid PET: Early Prediction of Suspected Brain Tumor Foci for Patient Management

Example of Artificial Intelligence-Based Decision Support for Amino Acid PET: Early Prediction of Suspected Brain Tumor Foci for Patient Management.

MRI and 18F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis

MRI and <sup>18</sup>F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis.

PET imaging of gliomas: Status quo and quo vadis?

Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib

Differentiation of a Falcine Meningioma From Cerebral Venous Sinus Thrombosis Using DOTATATE PET.

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas.

An updated review on the diagnosis and assessment of post-treatment relapse in brain metastases using PET.

Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET.

Two Decades of Brain Tumour Imaging with O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience

Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas.

Cost Effectiveness of <sup>18</sup>F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy.

Use of advanced neuroimaging and artificial intelligence in meningiomas.

Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups